caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1649266321

Sheldon GoldbergMD

Hematology-OncologySeattle, WAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
489
Unique beneficiaries
—
Total services
733
Distinct HCPCS
6
Medicare payment
$54K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 247 Hematology-Oncology providers in WA — below median (cohort median 770).
REFERRAL NETWORK

Where Sheldon Goldberg's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 15 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
DYNACARE NORTHWEST, INC1601,350
SWEDISH HEALTH SERVICES96922
SWEDISH HEALTH SERVICES45258
Robert Winrow
Nephrology · Seattle, WA
30296
Michael Peters
Diagnostic Radiology · Lynnwood, WA
23124
UNIVERSITY OF WASHINGTON1670
Brian Dontchos
Diagnostic Radiology · Seattle, WA
1547
Pacific Vascular Incorporated
Independent Diagnostic Testing Facility (IDTF) · Seattle, WA
1562
Cellnetix Labs, Llc
Clinical Laboratory · Tukwila, WA
1488
Michael Hayden
Internal Medicine · Scottsdale, AZ
12129
Benjamin Sacks
Diagnostic Radiology · Englewood, CO
1258
HARBORVIEW MEDICAL CENTER1256
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
785
Beneficiaries
—
Total drug cost
$2.4M
Distinct drugs
28
Brand share
41.7%
Top prescribed drugs
Ruxolitinib Phosphate93 claims
Apixaban81 claims
Hydroxyurea77 claims
Rivaroxaban72 claims
Gabapentin51 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
87.1
Quality
84.5
Cost
72.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.51%
Group